Using U87-MG intracranial xenografts, inhibitors of CXCR4 signaling such as peptide R and Plerixafor modulated the TAMs towards an anti-tumorigenic phenotype and inhibited the growth of glioma cells in vitro (111). This evidence concerns the gene CXCR4 and central nervous system cancer.